Skip to main content
. 2024 Jan 7;20(3):2034–2046. doi: 10.1002/alz.13655

FIGURE 6.

FIGURE 6

Gene‐based analysis comparing clinical rpAD and typical AD in NACC individuals. AD, Alzheimer's disease; EYS, The Eyes Shut Homolog; GABBR2, Gamma–Aminobutyric Acid Type B Receptor Subunit 2; NACC, National Alzheimer's Coordinating Center; rpAD, rapidly progressive Alzheimer's disease; TNN, Tenascin N; ZMAT4, Zinc Finger Matrin–Type 4